Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis
- 14 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (12) , e338-e340
Abstract
Laura Poujade, Guillaume Sarrabay, Renaud Cezar, Quentin Samaran, Pierre Corbeau, Didier Bessis, Tu-Anh Tran; Lenalidomide for treatment of refractory aphthosisKeywords
This publication has 7 references indexed in Scilit:
- The Clinical Chameleon of Autoinflammatory Diseases in ChildrenCells, 2022
- Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic DermatosisJAMA Dermatology, 2021
- First case of pyrin-associated autoinflammation with neutrophilic dermatosis complicated by amyloidosisRheumatology, 2020
- Neutrophilic figurate erythema of infancy: A diagnostic challengeJournal of Cutaneous Pathology, 2018
- A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean FeverAnnals of the Rheumatic Diseases, 2017
- Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activationScience Translational Medicine, 2016
- Successful Management of Refractory Pediatric-Onset Complex Aphthosis With LenalidomideJCR: Journal of Clinical Rheumatology, 2014